Juslina-5 Tablet is used to treat type 2 diabetes in adults along with diet and lifestyle changes. It is used alone or in combination with other drugs to lower blood sugar levels. People with type 2 diabetes either do not produce enough insulin, or the insulin produced cannot perform its function in the body (insulin resistance). Middle-aged or older individuals are most likely to suffer from type 2 diabetes, also known as adult-onset diabetes.

Juslina-5 Tablet contains Linagliptin, which belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. It works by blocking the action of DPP-4, an enzyme that destroys the hormone Incretin. The enzyme 'Incretins' helps produce more insulin only when required and reduces the liver's blood sugar level when not needed. 

The most common side effects of Juslina-5 Tablet are hypoglycaemia (low blood glucose levels), upper respiratory tract infection, nasopharyngitis (infection of nose and throat with common cold), and headache. Most of these side effects may not require medical attention and resolve gradually overtime. However, if the side effects persist or worsen, consult the doctor.

Do not take Juslina-5 Tablet if you are allergic to any of its components. If you stop taking Juslina-5 Tablet abruptly, it may increase your sugar levels, which could further increase the risk of eyesight loss (retinopathy), kidney (nephropathy) and nerve damage (neuropathy). Juslina-5 Tablet should not be taken if you have severe kidney or liver disease. Please inform your doctor if you have any heart disease or if you are pregnant, planning to get pregnant or breastfeeding.

Juslina-5 Tablet is primarily used to treat Type 2 diabetes mellitus. It contains Linagliptin, which belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors used Juslina-5 Tablet is prescribed for type 2 diabetes when diet and exercise alone cannot control blood sugar levels. It works by blocking the action of DPP-4 (an enzyme that destroys the hormone ‘Incretin’). The enzyme ‘Incretins’ helps produce more insulin only when required and reduces the liver's blood sugar level when not needed. Juslina-5 Tablet should not be used in patients with type 1 diabetes and for the treatment of diabetic ketoacidosis. Thus, Juslina-5 Tablet plays a vital role in controlling blood sugar levels and prevents serious complications of diabetes like eyesight loss (retinopathy), kidney (nephropathy), nerve damage (neuropathy), diabetic foot ulcer and delayed wound healing.

Juslina-5 Tablet should not be taken if you are allergic to Juslina-5 Tablet or any of its ingredients. Please inform your doctor if you are pregnant or breastfeeding before starting Juslina-5 Tablet . Prolonged intake of Juslina-5 Tablet may cause acute pancreatitis (swollen pancreas) and critical kidney problems. Increased risk of hypoglycaemia (low blood sugar level) can occur when Juslina-5 Tablet is added to other anti-diabetic agents or insulin therapy. In this case, your doctor may adjust the dose of Juslina-5 Tablet . Severe allergic reactions might occur in some patients taking Juslina-5 Tablet , like anaphylaxis, angioedema (swelling under the skin), and exfoliative skin conditions, including Stevens-Johnson syndrome. Safety and efficacy of Juslina-5 Tablet in children under 18 years have not been established, so it should not be given to them. Patients taking digoxin (a heart medicine) with Juslina-5 Tablet should be closely monitored as severe drug interaction has been observed. Juslina-5 Tablet should not be used in patients with type 1 diabetes and for the treatment of diabetic ketoacidosis.